Goodman Amends 13D Filing for Golden Matrix Group

Ticker: MRDN · Form: SC 13D/A · Filed: Nov 29, 2024 · CIK: 1437925

Sentiment: neutral

Topics: ownership-change, sec-filing, amendment

Related Tickers: GMGI

TL;DR

Goodman filed a 13D/A for GMGI, watch for ownership changes.

AI Summary

Anthony Brian Goodman filed an amendment (No. 7) to Schedule 13D on November 29, 2024, for Golden Matrix Group, Inc. The filing indicates a change in beneficial ownership of the company's common stock. Goodman is listed as the filer, with his address at 3651 Lindell Road, Suite D131, Las Vegas, NV.

Why It Matters

This amendment signals a potential shift in control or significant stake changes for Golden Matrix Group, Inc., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D often indicate significant changes in a major shareholder's position, which can lead to increased volatility.

Key Numbers

Key Players & Entities

FAQ

What specific changes in beneficial ownership are detailed in this Amendment No. 7?

The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership, but the specific details of the change (e.g., number of shares, percentage) are not provided in the excerpt.

Who is Anthony Brian Goodman in relation to Golden Matrix Group, Inc.?

Anthony Brian Goodman is identified as the person filing this Schedule 13D/A and is associated with the company's address at 3651 Lindell Road, Suite D131, Las Vegas, NV.

What is the CUSIP number for Golden Matrix Group, Inc. common stock?

The CUSIP number for Golden Matrix Group, Inc. common stock is 381098300.

When was the event that required this filing to be made?

The date of the event which requires filing of this statement is November 29, 2024.

What was Golden Matrix Group, Inc. formerly known as?

Golden Matrix Group, Inc. was formerly known as Source Gold Corp. and Ibex Resources Corp.

Filing Stats: 2,623 words · 10 min read · ~9 pages · Grade level 10.3 · Accepted 2024-11-29 17:00:05

Key Financial Figures

Filing Documents

Identity and Background

Item 2. Identity and Background The last three paragraphs of Item 2 are hereby amended and replaced by the following: As discussed under Item 4 hereof, the Reporting Persons may be deemed to be members of a " group " within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), comprised of the Reporting Persons and the following persons (the " Separately Filing Group Members "): Aleksandar Milovanovi, Zoran Milosevic, and Sneana Boovi It is the understanding of the Reporting Persons that the Separately Filing Group Members are filing separate Schedule 13Ds pursuant to Rule 13d-1(k)(2) under the Exchange Act addressing their respective statuses as members of a " group " with the Reporting Persons. The Reporting Persons do not assume responsibility for the information contained in the Schedule 13Ds filed by the Separately Filing Group Members, except to the extent such information has been provided by the Reporting Persons. Based on information provided by the Separately Filing Group Members, the Reporting Persons believe that they and the Separately Filing Group Members together as a " group " may be deemed to collectively beneficially own in the aggregate 121,783,696 total voting shares or 84.6% of the Issuer's total voting shares, as of the date of this Schedule 13D. The Reporting Persons expressly disclaim beneficial ownership of any securities beneficially owned or acquired by the Separately Filing Group Members. CUSIP No. 381098300 Schedule 13D/A Page 5 of 7

Purpose of Transaction

Item 4. Purpose of Transaction

is hereby amended and supplemented by adding the following at the end thereof

Item 4 is hereby amended and supplemented by adding the following at the end thereof: On November 29, 2024, Mr. Goodman entered into a Rule 10b5-1 Sales Plan with Oppenheimer & Co. Inc. (" Oppenheimer " and the " 10b5-1 Plan ") pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), for the purpose of selling shares of Common Stock in open market transactions. The description of the 10b5-1 Plan set forth in Item 6 below is incorporated herein by reference in its entirety. The transactions contemplated by the 10b5-1 Plan will result in the disposition of securities of the Issuer. The 10b5-1 Plan is intended to comply with Rule 10b5-1 under the Exchange Act, which permits persons to enter into a binding, pre-arranged plan to buy or sell Issuer stock at a time when such person is not in possession of material, nonpublic information about the Issuer. As described above, Mr. Goodman has adopted a trading plan in accordance with Rule 10b5-1 under the Exchange Act, in order to sell Common Stock. Otherwise, the Reporting Persons have no current plans or proposals that relate to or would result in any of the changes or transactions enumerated in subsections (a) - (j) of Item 4 of the General Instructions for Complying with Schedule 13D, although, depending on the factors discussed herein, the Reporting Persons may change their purpose or formulate different plans or proposals with respect thereto at any time.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer

is amended and restated in its entirety by the following

Item 5 is amended and restated in its entirety by the following: The information provided in Items 3 and 4 of this Schedule 13D is incorporated by reference herein. (a) and (b) The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the voting thereof, shared power to vote or to direct the voting thereof, sole power to dispose or to direct the disposition thereof, or shared power to dispose or to direct the disposition thereof, are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto. Item 2 and Item 4 of this Schedule 13D, which identifies the Reporting Persons and the Separately Filing Group Members and discloses the voting provisions of the Voting Agreement, is incorporated herein by this reference thereto. Due to the terms of the Voting Agreement, the Reporting Persons and Separately Filing Group Members may be deemed a group for the purposes of Section 13(d)(3) of the Exchange Act. The security interests reported in this Schedule 13D do not include security interests owned by the Separately Filing Group Members. The Separately Filing Group Members will file separate Schedule 13Ds reporting beneficial ownership of the Issuer's securities. The Reporting Persons assume no responsibility for the information contained in such Schedule 13Ds or any amendment thereto. The Separately Filing Group Members and the Reporting Persons may be deemed to collectively beneficially own in the aggregate 121,783,696 total voting shares or 84.6% of the Issuer's total voting shares. (c) The information in Item 3 is incorporated by reference into this Item 5(c) . (d) No other person has the right to receive or the power to direct the receipt of dividends from or the proceeds from the sale of the securities beneficially owned by the Reporting Persons. (e) N/

Contracts

Item 6. Contracts The information provided or incorporated by reference in Items 2 , 3 , 4 and 5 of this Schedule 13D, including, but not limited to the information regarding the Voting Agreement, is hereby incorporated herein by reference. 10b5-1 Plan Pursuant to the 10b-5-1 Plan, Mr. Goodman may sell up to 500,000 shares of Common Stock beneficially owned by Mr. Goodman, on the open market, subject to the satisfaction of certain conditions, including, among others, the Company's trading price. All sales under the 10b5-1 Plan are to be made in the discretion of Oppenheimer and in accordance with the terms, conditions and restrictions of the 10b5-1 Plan. Pursuant to the 10b5-1 Plan, potential sales begin on March 31, 2025 and will continue until August 8 th 2025, or until all of the shares of Common Stock to be sold under the 10b5-1 Plan are sold or the 10b5-1 Plan is otherwise terminated. The foregoing description of the 10b5-1 Plan is qualified in its entirety by the full text of the 10b5-1 Plan, the form of which is included as an exhibit to this Schedule 13D and is incorporated herein by reference.

Material to Be Filed as Exhibits

Item 7. Material to Be Filed as Exhibits Exhibit No. Description 1 Amended and Restated Certificate of Designation of Golden Matrix Group, Inc. Establishing the Designation, Preferences, Limitations and Relative Rights of its Series B Voting Preferred Stock as filed with the Secretary of State of Nevada on March 11, 2022, filed as Exhibit 10.1 to the Current Report on Form 8-K filed by the Issuer on March 14, 2022 (File No. 000-54840), and incorporated by reference herein 2 Asset Purchase Agreement dated February 22, 2016, by and between Source Gold Corp. and Luxor Capital, LLC, filed as Exhibit 10.1 to the Current Report on Form 8-K filed by the Issuer on February 29, 2016 (File No. 000-54840), and incorporated by reference herein 3 Joint Filing Agreement by and among Mr. Anthony Brian Goodman and Luxor Capital, LLC, dated March 12, 2021 4 Form of Golden Matrix Group, Inc. Notice of Restricted Stock Grant and Restricted Stock Grant Agreement (2022 Equity Incentive Plan)(officer and employee awards – September 2022)(Filed as Exhibit 10.3 to the Issuer's Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on September 20, 2022, and incorporated by reference herein). 5 Nominating and Voting Agreement dated April 9, 2024, by and between Golden Matrix Group, Inc., Aleksandar Milovanovi, Zoran Milosevic and Sneana Boovi (Filed as Exhibit 10.1 to the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on April 9, 2024, and incorporated herein by reference) 99.1 Form of Rule 10b5-1 Sales Plan (Filed herewith) CUSIP No. 381098300 Schedule 13D/A Page 7 of 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 29, 2024 /s/ Anthony Brian Goodman Anthony Brian Goodman November 29, 2024 Luxor Capital, LLC /s/ Anthony Brian Goodman Anth

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing